South Korean researchers have developed a new technology that can recognize and detect lung diseases such as Chronic Obstructive Pulmonary Disease (COPD), lung fibrosis, asthma, etc., by utilizing ...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for ...

Electronic nose (e-nose) technology identified early-stage lung cancer with high reliability in a prospective observational clinical trial conducted at Memorial Sloan Kettering Cancer Center (MSK).

Two new modeling studies suggest that expanding lung cancer screening — to include more smokers or even lifelong nonsmokers — would save thousands more lives in the US every year. But not everyone is ...

The Female Asian Nonsmoker Screening Study (FANSS) showed a 1.3% lung cancer detection rate among 1000 Asian women with no smoking history. The findings of FANSS, the largest lung cancer screening ...

E-cigarette use among individuals eligible for lung cancer screening was independently associated with a reduced likelihood of screening, a cross-sectional study of U.S. adults revealed. Compared with ...